Authors

  • Jurayeva G.A., Amanov A.K.
  • Mamadaliyeva Y.M.

Keywords:

Uterine cancer, immunohistochemical analysis, Bcl 2 and p53, tumor morphology, tissue expression.

References

Anikeeva N.V. The role of receptors for estrogens, progesterone, androgens, the HER2 tumor, and the Ki-67 antigen in the prognosis of breast cancer: Abstract of diss.... Cand. Medical Sciences. St. Petersburg, 2006. 25 p.

Bershtein L.M. Hormonal Carcinogenesis. St. Petersburg: Nauka, 2000. 199 p.

Bochkareva N.V., Kondakova I.V., Kolomiyes L.A. et al. Interrelation of apoptosis and neoangiogenesis with the activity of estrogen metabolism enzymes in endometrial tumors // Russian Oncological Journal. 2008. No. 1. 2008. P. 18-23.

Zakharseva L.M., Vorobeva L.I., Manzhura E.P. Morphological immunohistochemical prognostic criteria for cancer endometrium // Oncology. 2001. Vol. 3, No. 4. P. 252-256.

Kiselev V.I., Lyashenko A.A. Molecular mechanisms of regulation of hyperplastic processes. Moscow: Dimitreyd Grafik Grupp, 2005. 348 p. Kopnin B. P. // Biochemistry. 2000. Vol. 65, issue. 1. P. 5-33.

Larionov A.A. Conversion of androstendione in tumor and extragonadal tissues and its relationship with hormonal and metabolic factors in patients with breast cancer: Abstract of diss.... Cand. Medical Sciences. St. Petersburg, 1997. 25 p.

Lukashina M.I. // Clinical Laboratory Diagnostics. 2002. No. 8. Pp. 37-41.

Pojarisskiy K.M., Leenman E.E. The importance of immunohistochemical methods for determining the nature of treatment and prognosis of tumor diseases // Archives of Pathology. 2002. No. 5. P. 3-11.

Pojarisskiy K.M., Samsonova E.A., Ten V.P. Immunohistochemical profile of endometrioid adenocarcinoma of the uterine body: ER, PR, HER-2, Ki-67 and their prognostic significance // Archive of Pathology. 2005. No. 2. P. 13-17.

Samsonova E.A., Urmancheeva A.F., Pojarisskiy K.M. // Oncology Issues. 2004. Vol. 50, No. 2. P. 196-201.

Chernyshova A.L., Kolomiyes L.A., Sukhodolo I.V. Level of bcl-2 in unchanged, hyperplastic and malignant endometrium // Siberian Oncological Journal. 2003. No. 1. P. 18-21.

Shatseva T.A., Mukhina M.S. // Issues of Oncology.

Ing Pensi G. Superfamily of steroid hormone receptors: molecular mechanisms of action // Molecular Endocrinology. Moscow: Meditsina, 2003. P. 191-208.

Zayratyans O.V., Kolobov S.V., Akopyan K.V. et al. Features of expression of estrogen, progesterone, and nER-2 receptors by breast cancer cells // Archive of Pathology. 2004. No. 5. Pp. 9-12.

Hanson K.P. HER2/neu gene: from discovery to clinical use // Oncology issues. 2002. Vol. 48, No. 2. P. 137-145.

Korshunov A.G., Shishkina L.V., Golanov A.V. Proliferative markers in meningiomas: immunohistochemical study and analysis of prognostic significance // Archive of Pathology. 2002. No. 1. Pp. 29-33.

Sirlina E.V., Bernstein L.M. Hormone receptors as the main link in tumor hormone therapy // Hormone-dependent tumors: Materials of the IX All-Russian Conference. St. Petersburg, 2002. P. 82-86.

Agoff S.N., Swanson R.E., Linden N. et al. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations // Am. J. Clin. Pathol. 2003. Vol. 120 (5). P. 725-731.

Al-Ahwal M.S. nER-2 positivity and correlations with other histopathological features in breast cancer patients - hospital-based study // J. Pak. Med. Assoc. 2006. Vol. 56 (2). P. 65-68.

Barth A., Romer W., Oyettel M. Influence of subchronic administration of oyestrone-3-O-sulphamate on oyestrone sulphatease activity in liver, spleen and white blood cells of ovarictomy rats // Arch. Toxicol. 2000. Vol. 74 (7). P. 366-371. 22. Giatromanolaki A., Survidis E., Brekken R. et al. The angiogenic "vascular endothelial growth factor/flk-1 (KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications // Cancer. 2001. Vol. 92 (10). P. 2569-2577.

Hale G.E., Hughes C.L., Cline J.M. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones // J. Clin. Endocrinol. Metabol. 2002. Vol. 87. P. 3-15.

Ji Q., Chen P., Aoyoma C., Liu P. Increased expression of human luteinizing hormone/human chorionic gonadotropin receptor mRNA in human endometrial cancer // Mol. Cell Probes. 2002. Vol. - P. 269-275.

Jongen V.H., Hollema H., van der Zee A.G. et al. Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to toendometrioid endometrial cancer // Br. J. Obstet. Gynecol. 2003. Vol. 110. P. 690-695.

Liao C.K., Rosenblatt K.A., Schwartz S.M., Weiss N.S. Endometrial cancer in Asian migrants to the United States and their descendants // Cancer Causes Control. 2003. Vol. 14 (4). P. 357-360.

Liu W., Konduri S.D., Bansal S. Estrogen receptor-α directly binds to tumor suppressor protein p53 and represses its function // J. Biol. Chem. 2006. Vol. 281 (15). P. 9837-9840.

Lukanova A., Lundin E., Micheli A. et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women // Int. J. Cancer. 2004. Vol. 108. P. 425-432.

Maiorano E., Loverro G., Viale G. et al. Insulin-like growth factor I expression in normal and diseased endometrium // Int. J. Cancer. 1999. Vol. P. 188-193. 30. Peiro G., Diebold J., Baretton G.B. et al. Cell apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome // Int. J. Gynecol. Pathol. 2001. Vol. 20 (4). P. 359-367.

Phillips D.H. Understanding the genotoxicity of tamoxifen? // Carcinogenesis. 2001. Vol. 22. P. 839-849. Sayegusa M., Kamata Y., Isono M. et al. Bcl-2 expression correlates with a low apoptotic index and is associated with progesterone receptor immunoreactivity in endometrial carcinomas // J. Pathol. 1996. Vol. 180 (3). P. 272-275.

Sasano H., Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies // Endocrine Rev. 1998. Vol. 19. P. 593-607. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach // Mod. Pathol. 2000. Vol. 13. P. 295-308.

Utsunomiya H., Ito K., Suzuki T. et al. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma // Clin. Cancer Res. 2004. Vol. 10 (17). P. 5850-5856.

Veral A., Zekioglu O., Nart D. et al. P53, C-ERB, KI-67, estrogen and progesterone receptor expression and histological parameters in types I and II endometrial carcinomas // Ann. Saudi Med. 2002. Vol. 22 (3-4). P. 242-244.

Zalmasri N.M., Al Hamad M. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma // Breast Cancer Res. 2005. Vol. 7 (5). P. 598-604.